4//SEC Filing
Patel Samir Rashmikant 4
Accession 0000950170-24-141162
CIK 0001541157other
Filed
Dec 29, 7:00 PM ET
Accepted
Dec 30, 4:30 PM ET
Size
7.6 KB
Accession
0000950170-24-141162
Insider Transaction Report
Form 4
Patel Samir Rashmikant
Director
Transactions
- Award
Ordinary Shares, par value $0.0001 per share
2024-12-27$0.00/sh+400,000$200→ 5,249,303,500 total(indirect: By LLC) - Award
Ordinary Shares, par value $0.0001 per share
2024-12-26$0.00/sh+3,200,000$1,600→ 5,248,903,500 total(indirect: By LLC)
Holdings
- 91,396,000
Ordinary Shares, par value $0.0001 per share
Footnotes (3)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents 2,000 Ordinary Shares.
- [F2]On December 26, 2024, the Reporting Person acquired 3,200,000 Ordinary Shares at a purchase price of $0.0005 per Ordinary Share.
- [F3]On December 27, 2024 the Reporting Person acquired 400,000 Ordinary Shares at a purchase price of $0.0005 per Ordinary Share.
Documents
Issuer
Akari Therapeutics Plc
CIK 0001541157
Entity typeother
Related Parties
1- filerCIK 0001702447
Filing Metadata
- Form type
- 4
- Filed
- Dec 29, 7:00 PM ET
- Accepted
- Dec 30, 4:30 PM ET
- Size
- 7.6 KB